What is Better Therapeutics Price-to-Operating-Cash-Flow?
As of today (2024-06-10), Better Therapeutics's share price is $0.0125.
Better Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.95. Hence, Better Therapeutics's Price-to-Operating-Cash-Flow Ratio for today is .
The historical rank and industry rank for Better Therapeutics's Price-to-Operating-Cash-Flow or its related term are showing as below:
Better Therapeutics's Cash Flow from Operations per share for the
three
months ended in Sep. 2023 was $-0.15.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.95.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -67.10% per year.
During the past 4 years, Better Therapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was -67.10% per year. The lowest was -67.10% per year. And the median was -67.10% per year.
Better Therapeutics Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Better Therapeutics's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Better Therapeutics Price-to-Operating-Cash-Flow Chart
|
Better Therapeutics Annual Data
|
|
Trend |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
| Price-to-Operating-Cash-Flow |
|
- |
- |
- |
- |
|
Better Therapeutics Quarterly Data
|
|
Dec19 |
Jun20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
- |
- |
- |
- |
- |
Competitive Comparison of Better Therapeutics's Price-to-Operating-Cash-Flow
For the Biotechnology subindustry, Better Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Better Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Better Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Better Therapeutics's Price-to-Operating-Cash-Flow falls into.
Better Therapeutics Price-to-Operating-Cash-Flow Calculation
Better Therapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 0.0125 | / | -0.951 |
| = | |
Better Therapeutics's Share Price of today is $0.0125.
Better Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.95.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Better Therapeutics (Better Therapeutics) Business Description
Traded in Other Exchanges
N/A
Address
548 Market Street, Suite 49404, San Francisco, CA, USA, 94104
Better Therapeutics Inc is a prescription digital therapeutics company developing a novel form of cognitive behavioural therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions.
Executives
| Elder Granger |
director |
5176 S. LEWISTON WAY, CENTENNIAL CO 80015 |
| Mark A. Berman |
officer: Chief Medical Officer |
548 MARKET STREET, #49404, SAN FRANCISCO CA 94104 |
| Geoffrey M. Parker |
director |
15 RIORDAN PLACE, MENLO PARK CA 94025 |
| Frank Karbe |
director, officer: See Remarks |
C/O MYOVANT SCIENCES INC., 2000 SIERRA POINT PARKWAY, 9TH FLOOR, BRISBANE CA 94005 |
| David P Perry |
director, 10 percent owner, officer: See Remarks |
1020 EAST MEADOW CIRCLE, PALO ALTO CA 94303 |
| Andrew J. Armanino |
director |
C/O CALIFORNIA BANCORP, 1300 CLAY STREET, FIFTH FLOOR, OAKLAND CA 94612 |
| Georgianna Maule-ffinch 2015 Trust |
10 percent owner |
C/O BETTER THERAPEUTICS, INC., 548 MARKET STREET, #49404, SAN FRANCISCO CA 94104 |
| Mark Heinen |
officer: See Remarks |
548 MARKET STREET, #49404, SAN FRANCISCO CA 94104 |
| Risa J Lavizzo-mourey |
director |
GE HEALTHCARE TECHNOLOGIES INC., 500 W. MONROE ST., CHICAGO IL 60661 |
| Kevin J Appelbaum |
director, 10 percent owner, officer: Chief Executive Officer |
4160 DUBLIN BLVD., SUITE 200, DUBLIN CA 94568 |
| Suying Liu |
director |
311 WEST 43RD STREET, 12TH FLOOR, NEW YORK NY 10036 |
| Justin Zamirowski |
officer: Chief Commercial Officer |
548 MARKET STREET, #49404, SAN FRANCISCO CA 94104 |
| Kristin Wynholds |
officer: Chief Product Officer |
548 MARKET STREET, #49404, SAN FRANCISCO CA 94104 |
| Richard H Carmona |
director |
1221 BROADWAY, OAKLAND CA 94612 |
| David P. Perry 2015 Trust |
10 percent owner |
548 MARKET STREET, #49404, SAN FRANCISCO CA 94104 |
Better Therapeutics (Better Therapeutics) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BTTX has been successfully added to your